Timber Hill’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-6,655
Closed -$769K 1101
2017
Q1
$769K Buy
6,655
+4,725
+245% +$549K 0.01% 1230
2016
Q4
$232K Buy
+1,930
New +$214K ﹤0.01% 2005
2016
Q3
Sell
-9,249
Closed -$1.07M 2016
2016
Q2
$1.15M Buy
+9,249
New +$1.12M 0.01% 1186
2015
Q4
Sell
-4,249
Closed -$486K 2270
2015
Q3
$424K Buy
4,249
+2,234
+111% +$243K ﹤0.01% 1881
2015
Q2
$230K Buy
+2,015
New +$244K ﹤0.01% 2284

Other funds holding CLB

Timber Hill's CLB Position: Q2 2017 in Review

Timber Hill sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 6,655 shares — an estimated $769K sold.

Timber Hill first reported a position in CLB in Q2 2015 and held it in 5 quarters. The position peaked at $1.15M in Q2 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

  • Timber Hill reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 6,655 Core Laboratories shares in Q2 2017, an estimated $769K.
  • Timber Hill first reported a position in Core Laboratories in Q2 2015 and held it in 5 quarters.
  • Timber Hill's Core Laboratories position peaked at $1.15M in Q2 2016.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.